Trial NCT00730847

View at ClinicalTrials.gov 
Org. Study IDs: 108160
Secondary IDs: 2017-000458-20

Last trial update was posted on 2019-11-05

MeSH Interventions

Vaccines

MeSH Conditions

Papillomavirus Infections

Other Conditions

Human Papillomavirus Infection Leading to Cervical Cancer

Stopping Reasons

GSK received exemption from PDFDA on conduct of this post-marketing surveillance (PMS) study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID